Ownership history in CWM, LLC · 15 quarters on record
This page tracks every 13F SEC filing in which CWM, LLC reported a position in AKERO THERAPEUTICS INC (AKRO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 809 | +585 | +261.2% | 0.00% | $38K | — |
| 2025 Q2 | ADDED | 224 | +105 | +88.2% | 0.00% | $12K | — |
| 2025 Q1 | REDUCED | 119 | -16 | -11.9% | 0.00% | $5K | — |
| 2024 Q4 | ADDED | 135 | +15 | +12.5% | 0.00% | $4K | — |
| 2024 Q3 | ADDED | 120 | +89 | +287.1% | 0.00% | $3K | — |
| 2024 Q2 | REDUCED | 31 | -40 | -56.3% | 0.00% | $1K | — |
| 2024 Q1 | ADDED | 71 | +1 | +1.4% | 0.00% | $2K | — |
| 2023 Q4 | ADDED | 70 | +16 | +29.6% | 0.00% | $2K | — |
| 2023 Q3 | ADDED | 54 | +4 | +8.0% | 0.00% | $3K | — |
| 2023 Q2 | UNCHANGED | 50 | — | 0% | 0.00% | $2K | — |